Hypoacetylation which is partly mediated by histone deacetylase (HDAC), plays a causative role in the etiology of various clinical disorders.
10">HDAC inhibitors (HDACis) can restore or increase the level of histone acetylation.
15">HDACis as potential novel therapeutic agents could be used alone or in adjunct to other pharmacological agents in various clinical diseases.